Northern Trust Corp Neuronetics, Inc. Transaction History
Northern Trust Corp
- $690 Billion
- Q4 2024
A detailed history of Northern Trust Corp transactions in Neuronetics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 56,712 shares of STIM stock, worth $262,576. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56,712
Previous 56,712
-0.0%
Holding current value
$262,576
Previous $43,000
95.35%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding STIM
# of Institutions
49Shares Held
10.1MCall Options Held
24.1KPut Options Held
200-
Kent Lake Capital LLC Mill Valley, CA1.74MShares$8.05 Million1.44% of portfolio
-
Masters Capital Management LLC Atlanta, GA1.5MShares$6.95 Million0.08% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.48MShares$6.86 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.28MShares$5.93 Million0.0% of portfolio
-
Four World Capital Management LLC New York, NY858KShares$3.97 Million0.69% of portfolio
About Neuronetics, Inc.
- Ticker STIM
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,022,800
- Market Cap $125M
- Description
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...